CD200 and hematologic disorder: CD200 has been shown to play an important role in the regulation of anti-tumor immunity, and overexpression of CD200 has been reported in a number of hematological malignancies and solid tumors as well as on cancer stem cells (Alapat et al. 2012; Kawasaki et al. 2007; Petermann et al. 2007).